2014 OUTCOMES ONCOLOGY
TABLE OF CONTENTS 4-9 // Outcomes Data 4 // Liver Cancer 5–Year Survival 4 // Pancreas Cancer 5–Year Survival 5 // Lung Cancer 5–Year Survival 5 // Melanoma of the Skin 5 –Year Survival 6 // Breast Cancer 5–Year Survival 6 // Corpus Uteri Cancer 5–Year Survival 7 // Thyroid Cancer 5–Year Survival 7 // Prostate Cancer 5–Year Survival 8 // Brain & CNS (Malignant Only) Survival by Year 8 // Head & Neck Cancer 5–Year Survival 9 // Lymphoma 5–Year Survival 9 // Kidney & Renal Pelvis 5–Year Survival 10 // Colorado’s Only Federally Designated Cancer Center
UNIVERSITY OF COLORADO HOSPITAL IS ONE OF THE LEADING ACADEMIC MEDICAL CENTERS IN THE NATION. For several years, the University of Colorado Hospital (UCH) has been ranked at the top or near the top of many hospital rankings such as University HealthSystem Consortium and US News & World Report. Best known as an innovator in patient care, UCH is often one of the first hospitals to bring new medicine to the patient’s bedside. Because of its affiliation with the NCI-designated Comprehensive Cancer Center, CU Cancer Center, UCH plays a significant role in the country’s clinical trials landscape in the field of oncology. The hospital’s physicians are affiliated with the University of Colorado School of Medicine and its primary facilities are located at the nationally-renowned Anschutz Medical Campus in Aurora, CO.
ONCOLOGY OUTCOMES DATA LIVER CANCER - 5 YEAR SURVIVAL UCH Colorado National 51.8%
13.7% 11.1% 3.8%
6.7% 1.8% 2.4%
PANCREAS CANCER - 5 YEAR SURVIVAL UCH Colorado National
24.0% 22.5% 21.3%
3.3% 2.0% 1.7%
LUNG CANCER - 5 YEAR SURVIVAL UCH Colorado National
17.0% 11.7% 12.2% 5.3%
MELANOMA OF THE SKIN - 5 YEAR SURVIVAL 92.8%
UCH Colorado National
67.3% 67.9% 66.2% 59.7%
11.8% 10.2% 13.6%
ONCOLOGY OUTCOMES DATA BREAST CANCER - 5 YEAR SURVIVAL 95.5%
UCH Colorado National 88.8%
37.3% 27.2% 22.7%
CORPUS UTERI - 5 YEAR SURVIVAL UCH Colorado National
87.8% 89.8% 88.0% 80.8% 75.2% 73.6%
75.2% 63.0% 54.5%
22.7% 15.4% 17.2%
THYROID CANCER - 5 YEAR SURVIVAL 94.8%
UCH Colorado National
PROSTATE CANCER - 5 YEAR SURVIVAL 93.1%
UCH Colorado National
Stage III *n=14
ONCOLOGY OUTCOMES DATA BRAIN & CNS (MALIGNANT ONLY) SURVIVAL BY YEAR UCH Colorado National 71.1%
HEAD & NECK CANCER - 5 YEAR SURVIVAL UCH Colorado National
76.0% 76.4% 69.6% 62.0% 61.7%
LYMPHOMA - 5 YEAR SURVIVAL UCH Colorado National 82.8%
73.1% 62.8%62.8% 61.7% 54.1% 52.2%
KIDNEY & RENAL PELVIS - 5 YEAR SURVIVAL UCH Colorado National 84.3% 84.1% 83.7% 79.1% 72.0%
75.7% 65.7% 55.9%
Stage III *n=19
NCI CANCER CENTERS IN THE USA
=NCI Laboratory = NCI Cancer Center = NCI Comprehensive Cancer Center = UCH, NCI Comprehensive Cancer Center
COLORADOâ€™S ONLY FEDERALLY DESIGNATED CANCER CENTER
TACKLES CANCER FROM ALL ANGLES The University of Colorado Cancer Center is the hub of cancer research in Colorado. We are a consortium of more than 400 researchers and physicians at three state universities and six institutions, all working toward one goal: translating science into cancer survivorship.
THROUGH COLLABORATION AND INNOVATION, CU CANCER CENTER MEMBERS DISCOVER, DEVELOP AND DELIVER BREAKTHROUGHS THAT IMPROVE CANCER CARE FOR PEOPLE AND COMPANION ANIMALS. WE FOCUS ON: Personalized care that embraces the best clinical practices
Cancer survivorship. We’re one of eight LIVESTRONG
of prevention, diagnosis, treatment and survivorship.
Cancer Survivorship Centers of Excellence and home to the region’s three full-scale cancer survivorship clinics: The
• Innovative interdisciplinary research.
HOPE clinic for young adult survivors of cancer at Children’s
• Premier clinical and scientific training.
Hospital Colorado, the TACTIC clinic for adult survivors of
• Creative partnerships.
childhood cancer at University of Colorado Hospital, and the
Founded in 1988, CU Cancer Center is the only
THRIVE clinic for transitioning adult cancer patients back to
comprehensive cancer center designated by the National
Cancer Institute in Colorado and the Rocky Mountain
Cancer screening. The Colorado Colorectal Screening
region. Our founding director, Paul A. Bunn, Jr., MD, led the
Program is a national model for ensuring uninsured
organization until 2009. In 2010, Dan Theodorescu, MD, PhD,
Coloradans who meet certain financial and risk criteria
ushered CU Cancer Center into a new era.
receive colon cancer screening and follow-up care at no cost to them.
CU Cancer Center is headquartered on the Anschutz Medical Campus in Aurora, Colo., in the University of Colorado
Molecular tumor testing. CU Cancer Center has developed
School of Medicine. Affiliated institutions include University
tests that find specific gene defects that can be targeted with
of Colorado Denver, University of Colorado Boulder,
new drugs. These tests have positioned CU Cancer Center as
Colorado State University (including its Flint animal cancer
a national leader for clinical trials of “targeted” drugs.
center), University of Colorado Health, Children’s Hospital Colorado, Denver Veterans Affairs Medical Center, Denver
Cancer clinical trials. CU Cancer Center’s Phase I Trials
Health, National Jewish Health and the Kaiser Permanente’s
program is the only program of its kind in the region and
Institute of Health Research. Our clinical outreach program
nationally recognized. In addition, with the largest number
extends throughout Colorado and neighboring states.
of human cancer clinicals in the region, CU Cancer Center provides patients across the state and region with access to
HIGHLIGHTS AND ACCOMPLISHMENTS
cutting-edge cancer care.
CU Cancer Center is known clinically for its personalized
have helped recruit world-class scientists to use them. The
cancer treatments and robust and diverse clinical research
machines, housed in CU Cancer Center’s Structural Biology
and trials program and. Our scientific expertise ranges from
shared resource, help scientists solve structures of cancer
understanding how chromosome structure controls cancer
molecules to develop drugs with precise molecular targeting.
Structural biology. CU Cancer Center’s NMR spectroscopy and X-ray facilities are among the best in the world and
cell behavior, to understanding how the immune system impacts cancer to carrying out Phase I trials that bring new
Animal cancer treatment. The Colorado State University
therapies to market. Other strengths include:
Flint Animal Cancer Center is the world leader in research and treatment of spontaneously occurring cancers in
NCCN member. The CU Cancer Center is a member of the
companion animals, especially dogs. CU Cancer Center’s
National Comprehensive Cancer Network, an alliance of 23
members at CSU collaborate with researchers in human
of the world’s leading cancer centers dedicated to improving
cancers, and clinical trials in dogs have led to new
the quality, effectiveness and efficiency of care provided to
treatments for people.
patients with cancer.
Lung cancer care and research. CU Cancer Center is one of the world’s best lung cancer research and
treatment programs. We are the coordinating center for
the Lung Cancer Mutations Consortium, funded by a $5.3
million American Reinvestment and Recovery Act Grand
Opportunities grant. 11
University of Colorado Hospital oncology outcomes data for 2014.